Limulus Amebocyte Lysate (LAL) has been the foundation of bacterial endotoxin testing (BET) and the basis of QC workflows for decades, but the road ahead is quickly evolving. The future of microbial quality control demands more…more precision, more efficiency, and more innovation. As more laboratories explore options in recombinant, animal-free methods, the challenge isn’t just adopting new technology; it’s building robust, compliant workflows that accelerate efficiency and sustainability.

The Recombinant BET Roadshow is your chance to learn how to shift gears. This half-day experience is designed for QC lab directors, managers, and MSAT scientists ready to explore the fast lane of endotoxin testing innovation. We’re bringing practical insights, transformative alternatives, and regulatory strategies straight to you to help you maintain consistent quality standards, because the future of QC doesn’t wait. 

What you'll gain:

• Recombinant Method Deep Dive: Compare approaches and understand the science behind the shift.
• Implementation and Validation Playbook: Practical steps to make the transition seamless and how to confidently scale adoption across your lab.
• Global Regulatory Roadmap: Navigate evolving expectations with confidence.
• Sustainability in Action: Learn how green methods can transform your QC footprint.

Pack your questions and drive towards the future of BET with an interactive experience that puts innovation in motion for modernizing your lab.

Join us where innovation meets compliance, and sustainability drives every mile.

We reserve the right, at our sole discretion, to deny registration or remove any individual who is not a confirmed current or potential client/partner of Charles River.